Adenoma News and Research

RSS

Adenoma (Benign Tumor) is a noncancerous tumor that starts in gland-like cells of the epithelial tissue (thin layer of tissue that covers organs, glands, and other structures within the body).

Rising colorectal cancer risk in young adults calls for earlier screening, study suggests

Study reveals an increase in adenomas and advanced adenomas in younger adults, alongside a rise in colorectal cancer incidence in males under 50, suggesting a need for earlier screening, particularly in men.

7 Dec 2023

AI transforms colonoscopy: Boosting detection rates, slashing miss rates in cancer screening

Researchers in China have demonstrated through a systematic review and meta-analysis that AI-based methods significantly enhance adenoma detection rates and reduce miss rates during colonoscopies, potentially improving colorectal cancer screening and reducing mortality.

3 Dec 2023

Hormones and high blood pressure: Study reveals endocrine culprits and targeted treatments

Researchers delve into endocrine causes of hypertension (HTN), revealing key culprits like primary aldosteronism and Cushing's syndrome. The study also evaluates the efficacy of various treatments, offering valuable insights for tackling this widespread health issue.

15 Oct 2023

Unlocking the genetic code of blood sugar reveals new diabetes risks and lung complications

The study used a genome-wide association study (GWAS) to analyze random glucose levels in nearly half a million non-diabetic subjects, uncovering 150 distinct genetic signals, including 53 new ones, linked to glycemic traits and type 2 diabetes. The research also discovered a causal effect of random glucose and type 2 diabetes on lung function, identifying lung dysfunction as a new diabetes complication.

10 Sep 2023

Reversing β-cell failure: A promising approach for type 2 diabetes treatment

Researchers examined current evidence on the reasons and implications of pancreatic beta-cell failure.

3 Aug 2023

COLOTECT 1.0 receives market authorization from Malaysia's Medical Device Authority

Recently, BGI Genomics' COLOTECT 1.0 DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C Genes (Real-Time PCR), Sample Pretreatment Kit for Methylation Detection, DNA Isolation Kit, Stool Sample Collection Kit have received market authorization from Malaysia's Medical Device Authority (hereinafter referred to as MDA).

6 Jun 2023

Eating garlic may lower risk of colorectal cancer, study finds

Research investigates the association between garlic consumption and colorectal cancer risk, as well as the influence of garlic consumption on bacterial DNA in the blood. The study found that garlic consumption was inversely associated with colorectal cancer risk and that it influenced the gut microbiota.

26 Apr 2023

Global Colorectal Cancer Awareness Report Reveals Lack of Symptoms Holding Hungarians Back from Screening

To uncover attitudes and the biggest challenges facing colorectal cancer (CRC) awareness and screening, BGI Genomics released its State of Colorectal Cancer Awareness Report, marking the first-ever global survey report on the world’s third most common cancer. This report seeks to motivate action to tackle the health challenges of today and tomorrow.

From BGI Genomics 20 Apr 2023

New report seeks to uncover attitudes, challenges facing colorectal cancer awareness and screening

To uncover attitudes and the biggest challenges facing colorectal cancer (CRC) awareness and screening, BGI Genomics today released its State of Colorectal Cancer Awareness Report, marking the first-ever global survey report on the world's third most common cancer.

7 Apr 2023

General Awareness Gaps and Affordability Concerns Revealed with State of Colorectal Cancer Awareness Report

From BGI Genomics 7 Apr 2023

BGI Genomics and Zentya collaborate to launch first-ever fecal DNA tests for colorectal cancer in Slovakia

BGI Genomics is pleased to announce the launch of COLOTECTTM 1.0 in Slovakia, in collaboration with its local partner, Zentya.

30 Mar 2023

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

In this interview, NewsMedical speaks with Dr. Yuying Wang, R&D Director (Oncology), from BGI Genomics, about colorectal cancer and the development and application of COLOTECT® 1.0, a non-invasive fecal DNA test for the detection of colorectal cancer and pre-cancerous lesions.

From BGI Genomics 27 Mar 2023

Government funding to accelerate research in AI healthcare technologies

Tens of thousands of patients across the country could benefit from quicker, earlier diagnoses and more effective treatments for a range of conditions - as the government invests nearly £16 million into pioneering artificial intelligence research (AI).

3 Mar 2023

New scan reliably detects primary aldosteronism, a common cause of hypertension

In a recent article, researchers performed a prospective within-patient clinical trial, Is Metomidate superior to AVS in predicting ouTComes from adrenalectomy in primary Hyperaldosteronism (MATCH) in the United Kingdom (UK) in primary aldosteronism (PA) patients. These patients suffered from high blood pressure caused by a steroid hormone, aldosterone.

19 Jan 2023

AI can improve the effectiveness of colonoscopy in the presence of Lynch syndrome

First study of AI-assisted colonoscopy for colorectal cancer surveillance in patients with genetic predisposition - People with Lynch syndrome have a higher hereditary risk of colon cancer.

28 Dec 2022

Research: Patient's race may influence recommendations for surgical resection of brain tumors

Published in The Lancet, University of Minnesota Medical School researchers found a patient's race may influence recommendations for surgical removal of brain tumors.

15 Dec 2022

Using DECT-derived metrics to definitively diagnose incidental adrenal adenomas

According to an open-access Editor's Choice accepted manuscript published in ARRS' American Journal of Roentgenology, for adrenal lesions evaluated by single-phase dual-energy CT (DECT), fat fraction had higher sensitivity than virtual non-contrast attenuation at both the clinically optimal threshold and at the traditional ≤10 HU threshold.

1 Dec 2022

Novel molecular imaging radiotracer can precisely diagnose multiple cancers

A new molecular imaging radiotracer can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies.

20 Nov 2022

Lower risk of colorectal cancer associated with dietary flavanone and anthocyanidin intake, according to new research

In a new study, researchers assessed the risk of colorectal cancer (CRC) with the intake of flavonoids.

31 Oct 2022

ACR TI-RADS, deep learning algorithm offer alternative strategies for evaluating thyroid nodules

According to an accepted manuscript published in ARRS' American Journal of Roentgenology (AJR), ACR TI-RADS and a deep learning algorithm trained on adult populations offer alternative strategies for evaluating thyroid nodules in children and younger adults, including guiding decisions to perform fine-needle aspiration.

19 Oct 2022